| 标题 |
 Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1 |
| 网址 | |
| DOI |
10.1136/jitc-2025-012749
doi
|
| 其它 |
期刊：Journal for ImmunoTherapy of Cancer 作者：Gary Middleton; Charlotte Gaskell; Joshua Savage; John Bridgewater; Paul Ross; et al 出版日期：2025-12-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Criminology34
秋风
null
Nole
Ali
Kao
GingerF
斯文的白玉
Lo
罗Eason
OK
无极微光
cdercder
Freya1528
学术文献互助
嘉心糖
今夕何夕
Rita
CRUSADER
12Nightz
皖公网安备34019202002308
